INDUSTRY REPORT
The strategic horizon: five forces shaping the metabolic care landscape
The groundbreaking impact GLP-1s have had on patients’ health has turned the page for how organizations across the health care continuum approach weight care. While diet and exercise remain critical pieces to achieving sustainable health outcomes, medication has proven to be an effective lever for clinicians to treat and manage obesity, especially as it is a condition deeply rooted in a person’s biology.
Because of the multi-faceted nature of this disease, employers need to design their strategic priorities with an emphasis on future-proofing. It is paramount for benefits leaders and consultants to consider five key forces shaping the weight care and metabolic health horizon in 2025:
- The new path to cost-containment provided by compounded GLP-1s
- The significance of clinical oversight in prescribing anti-obesity medications
- The broad toolkit of weight care therapies available to address metabolic health
- The importance of data in measuring the success of health solutions
- The role of personalized metabolic care in prioritizing preventative care
